U.S. President Donald Trump said on Friday that he would sign four executive orders that would lead to a “massive reduction” in drug costs. He said it would restructure the prescription drug market, including allowing the safe and legal importation of prescription drugs from Canada and other countries. He said an “identical drug” may have a much lower price tag elsewhere than a drug made in the U.S.
- Health Canada delays drug-pricing reforms until July 1, citing coronavirus challenges
- Canada blocks key prescription drugs exports after Trump import plan risks shortages
- Trump signs orders to lower drug prices, including by importing from Canada